Clinica Baviera
Research Clinica Baviera (CBAV) on Bullrun: market cap EUR 942.75M, P/E 20.5, dividend yield 2.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCBAV
- ExchangeMC
- CountrySpain
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 942.75M
- P/E20.5
- Dividend yield2.7%
- Financial periodQ2 2026
- RevenueEUR 82.96M
- Net incomeEUR 11.51M
- Free cash flowEUR 12.74M
Valuation Snapshot
latest market cap is EUR 942.75M; P/E is 20.5; dividend yield is 2.7%.
Peer valuation comparison
Latest P/E is 20.48x versus a Healthcare sector median of 24.46x (16.3% below).
Latest dividend yield is 2.68% versus a Healthcare sector median of 2.11% (27.0% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 301.78M | EUR 42.06M | EUR 46.83M | n/a | n/a | EUR 5.59M | EUR 70.62M | EUR 109.99M |
| FY2024 | EUR 262.65M | EUR 41.14M | EUR 36.00M | n/a | n/a | EUR 10.14M | EUR 63.47M | EUR 96.92M |
| FY2023 | EUR 224.92M | EUR 36.73M | EUR 35.13M | n/a | n/a | EUR 8.31M | n/a | EUR 91.00M |
| FY2022 | EUR 198.45M | EUR 30.15M | EUR 39.35M | n/a | n/a | EUR 19.17M | n/a | EUR 67.34M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 942.75M | 20.5 | 2.7% | 1.57 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.57 EUR, yield 2.7%.
| Year | Dividends/share |
|---|---|
| FY2024 | 1.57 EUR |
| FY2023 | 0.8 EUR |
| FY2022 | 1.03 EUR |
About Clinica Baviera
Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Clinica Baviera's market cap?
Clinica Baviera's market capitalization is EUR 942.75M.
What is Clinica Baviera's P/E ratio?
Clinica Baviera's price-to-earnings (P/E) ratio is 20.5.
Does Clinica Baviera pay a dividend?
Clinica Baviera has a dividend yield of 2.7%.
What does Clinica Baviera do?
Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A.